These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4462541)

  • 1. Hydroxyurea and bronchogenic carcinoma.
    Ahmad A
    Australas Radiol; 1974 Dec; 18(4):393-7. PubMed ID: 4462541
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
    Bonadonna G; Tancini G; Bajetta E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer: perspectives and prospects.
    Ann Intern Med; 1970 Dec; 73(6):1003-24. PubMed ID: 4336754
    [No Abstract]   [Full Text] [Related]  

  • 5. Split-course irradiation compared to split-course irradiation plus hydroxyurea in inoperable bronchogenic carcinoma--a randomized study of 53 patients.
    Landgren RC; Hussey DH; Barkley HT; Samuels ML
    Cancer; 1974 Nov; 34(5):1598-601. PubMed ID: 4426027
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyurea (NSC-32065) in therapy for nonresectable cancer of the lung.
    Kaung DT; Walsh WS; Sbar S; Patno ME
    Cancer Chemother Rep; 1968 Feb; 52(2):271-4. PubMed ID: 4869288
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonsurgical treatment of pulmonary neoplasm.
    Shnider BI; Zevallos P
    Med Ann Dist Columbia; 1966 Oct; 35(10):528-30. PubMed ID: 5223193
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
    Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
    Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
    Castro L
    W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity.
    Ruckdeschel JC; Baxter DH; McKneally MF; Killam DA; Lunia SL; Horton J
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1323-8. PubMed ID: 528285
    [No Abstract]   [Full Text] [Related]  

  • 11. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
    Whittington RM; Fairly JL; Majima H; Patno ME; Prentice R
    Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of lithium carbonate administration in patients with advanced small cell bronchogenic carcinoma receiving combination chemotherapy and radiotherapy.
    Lyman GH; Williams CC; Dinwoodie WR; Preston D
    Adv Exp Med Biol; 1980; 127():207-29. PubMed ID: 7405722
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiotherapy of bronchogenic carcinoma.
    Lee RE
    Semin Oncol; 1974 Sep; 1(3):245-52. PubMed ID: 4143487
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
    Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of irradiation and vinblastine in lung cancer.
    Coy P
    Cancer; 1970 Oct; 26(4):803-7. PubMed ID: 5506603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemoradiotherapy of non-small-cell bronchogenic carcinoma].
    Coupek P; Seneklová Z; Perková H; Kebedeová D
    Cas Lek Cesk; 2003; 142 Suppl 1():40-3. PubMed ID: 12924050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer.
    Band PR; Ross CA; Holland JF
    Cancer Chemother Rep; 1973 Feb; 57(1):79-82. PubMed ID: 4704106
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchogenic carcinoma in chronic lymphocytic leukemia.
    Amamoo DG; Moayeri H; Takita H; Han T
    Chest; 1979 Feb; 75(2):174-7. PubMed ID: 421552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study comparing irradiation alone to irradiation plus procarbazine in inoperable bronchogenic carcinoma.
    Landgren RC; Hussey DH; Samuels ML; Leary WV
    Radiology; 1973 Aug; 108(2):403-6. PubMed ID: 4578183
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.